1st Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for AMIVAS, LLC

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA post-approval of malaria products

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Homeland Security HOM

FDA post-approval of malaria products

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

FDA post-approval of malaria products

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Veterans VET

FDA post-approval of malaria products

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.